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Introduction
How cells physically organize and compartmentalize receptors and signaling molecules into specialized, effi cient, regulated networks is of critical importance to our understanding of the complexity and dynamics of biological processes. In this regard, cholesterol and sphingolipid-enriched rafts have been proposed as platforms for the sorting of specific membrane components, such as glycosylphosphatidylinositol (GPI)anchored proteins, and as sites for the assembly of cytoplasmic signaling complexes ( Simons and Toomre, 2000 ; Anderson and Jacobson, 2002 ) . Recent biochemical, proteomic, and structural studies bolster the idea that tetraspanin-enriched microdomains (TEMs) at the plasma membrane play a key role in organizing molecular complexes with protein compositions different from those of typical lipid rafts ( Hemler, 2005 ; Le Naour et al., 2006 ; Min et al., 2006 ) . The existence and physical properties of lipid rafts have been extensively studied by innovative analytical methods ( Kenworthy et al., 2004 ; Sharma et al., 2004 ; Larson et al., 2005 ; Suzuki et al., 2007 ) . However, the presence and molecular dynamics of TEMs on the plasma membrane of living cells have not been explored.
Tetraspanins are ubiquitous, low molecular weight proteins that span the plasma membrane four times and are able to organize themselves by homo-and heterooligomerization ( Hemler, 2005 ) . Moreover, these molecules can simultaneously associate laterally V CAM-1 and ICAM-1, receptors for leukocyte integrins, are recruited to cell -cell contact sites on the apical membrane of activated endothelial cells. In this study, we show that this recruitment is independent of ligand engagement, actin cytoskeleton anchorage, and heterodimer formation. Instead, VCAM-1 and ICAM-1 are recruited by inclusion within specialized preformed tetraspanin-enriched microdomains, which act as endothelial adhesive platforms (EAPs). Using advanced analytical fl uorescence techniques, we have characterized the diffusion properties at the single-molecule level, nanoscale organization, and specifi c intradomain molecular interactions of EAPs in living primary endothelial cells. This study provides compelling evidence for the existence of EAPs as physical entities at the plasma membrane, distinct from lipid rafts. Scanning electron microscopy of immunogold-labeled samples treated with a specifi c tetraspanin-blocking peptide identify nanoclustering of VCAM-1 and ICAM-1 within EAPs as a novel mechanism for supramolecular organization that regulates the leukocyte integrin -binding capacity of both endothelial receptors during extravasation.
Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms enhance their adhesive properties during leukocyte adhesion to endothelium. By using advanced analytical fl uorescence microscopy techniques, we have determined the molecular characteristics, dynamics, and biophysical properties of EAPs. Finally, using scanning electron microscopy in combination with tetraspanin-blocking peptides, we show that tetraspanin microdomains make an essential contribution to the avidity regulation of endothelial adhesion receptors, fi ne-tuning their adhesive properties.
Results
Endothelial ICAM-1 and VCAM-1 cluster at the docking structure independently of counterreceptor engagement and actin anchorage We have previously shown that at contact sites with adherent leukocytes, activated endothelial cells form three-dimensional actin-based docking structures that cluster VCAM-1 and ICAM-1 ( Barreiro et al., 2002 ) . To analyze the dynamic recruitment of adhesion molecules to these docking structures, we induced their formation with K562 cells expressing either ␣ 4 ␤ 1 or ␣ L ␤ 2 integrins (K562 ␣ 4 or K562 lymphocyte function-associated antigen -1 [LFA-1]), which adhere to activated endothelial cells via VCAM-1 or ICAM-1, respectively. Surprisingly, both ICAM-1 and VCAM-1 clustered at the docking structure formed around either K562 clone, regardless of whether they were directly engaged by their corresponding integrin receptor ( Fig. 1 A ) . To assess the generality of this corecruitment, we examined the docking structures formed with T lymphoblasts, which express both LFA-1 and very late antigen -4 (VLA-4); before adhesion to activated human umbilical vein endothelial cells (HUVECs), LFA-1 was blocked with a specifi c allosteric antagonist (BIRT377), or VLA-4 was blocked with a ligand-binding inhibitor (BIO5192). In both cases, VCAM-1 and ICAM-1 were corecruited in a similar way as observed with K562 cells ( Fig. 1 B ) .
To assess the involvement of the endothelial actin cytoskeleton in VCAM-1 -ICAM-1 corecruitment, we transiently transfected resting HUVECs with a cytoplasmic tail -truncated VCAM-1 mutant (VCAM ⌬ Cyt). Under these conditions, HUVECs bear low levels of ICAM-1 and negligible levels of endogenous VCAM-1. Upon engagement of VCAM ⌬ Cyt by K562 ␣ 4, discrete clusters containing VCAM ⌬ Cyt and ICAM-1 were observed around adhered cells, but in no case was a well-developed three-dimensional structure formed ( Fig. 1 C , i) . In contrast, when ICAM-1 was directly engaged by K562 LFA-1, a proper docking structure was formed, also containing VCAM ⌬ Cyt ( Fig. 1 C , ii) . Likewise, wellformed docking structures containing ICAM-1 and VCAM ⌬ Cyt were induced by adhered T lymphoblasts ( Fig. 1 C , iii) . These data suggest that the engagement of one endothelial adhesion receptor by its corresponding leukocyte integrin corecruits the other receptor toward the contact area. This coclustering must involve the extracellular or transmembrane domains of both adhesion molecules because it occurs with cytoplasmic tail -truncated forms. However, subsequent reorganization of the endothelial actin cytoskeleton into the protrusive cup requires actin anchorage of the cytoplasmic tail of the ligand-bound endothelial adhesion molecule.
at the plasma membrane with numerous integral membrane receptors, modulating their functions and organizing discrete, dynamic plasma membrane compartments. These partners include integrins and other adhesion molecules ( Yanez-Mo et al., 1998 ; Berditchevski, 2001 ; Barreiro et al., 2005 ) , CD19 -CD21 ( Cherukuri et al., 2004 ; Levy and Shoham, 2005 ) , major histocompatibility complex -peptide complexes ( Kropshofer et al., 2002 ) , Fc receptors ( Moseley, 2005 ) , G protein -coupled receptors ( Little et al., 2004 ) , and metalloproteinases ( Yan et al., 2002 ) . Tetraspanins also associate intracellularly with several cytoplasmic signaling mediators such as type II PI4K or PKC isoforms ( Yauch and Hemler, 2000 ; Zhang et al., 2001 ) . Apart from acting as adapters for membrane organization, tetraspanins also regulate the traffi cking and biosynthetic processing of associated receptors ( Berditchevski and Odintsova, 2007 ) . Although TEMs seem to be different from biochemically defi ned lipid rafts ( Simons and Toomre, 2000 ) , they are not devoid of lipid interactions because tetraspanins are highly palmitoylated proteins that bind cholesterol and gangliosides ( Charrin et al., 2003 ; Yang et al., 2004 ) .
The composition and other specifi c characteristics of TEMs may vary with cell type. Gene deletion, knockdown, overexpression, and mutation experiments have revealed key functional roles for tetraspanins in many fundamental physiological processes, among which are egg -sperm fusion ( Le Naour et al., 2000 ; Miyado et al., 2000 ) , antigen presentation ( Kropshofer et al., 2002 ; Levy and Shoham, 2005 ; Unternaehrer et al., 2007 ) , viral cell entry and budding and virus-promoted syncytia formation ( Pileri et al., 1998 ; Gordon-Alonso et al., 2006 ; Nydegger et al., 2006 ) , kidney failure and tissue angiogenesis ( Sachs et al., 2006 ; Takeda et al., 2007 ) , and cell adhesion, migration, and invasion ( Yanez-Mo et al., 1998 Chattopadhyay et al., 2003 ; Hemler, 2003 ; Barreiro et al., 2005 ) . Because there are few known tetraspanin ligands, it is very likely that these molecules exert their regulatory effects indirectly through their lateral binding to assorted partners. However, the molecular mechanisms underlying the regulatory activity of tetraspanins remain elusive.
Leukocyte extravasation from the bloodstream to sites of infection and infl ammation involves a dynamic interaction with the endothelium that is mediated by an array of leukocyte and endothelial cell surface receptors. This process consists of sequential steps of tethering, rolling, fi rm adhesion, locomotion, and diapedesis, with specialized receptor/ligand pairs involved in each ( Ley et al., 2007 ) . Previous studies have shown that, to prevent leukocyte detachment under hemodynamic fl ow, endothelial cells form actin-based structures that cluster VCAM-1, ICAM-1 ( Barreiro et al., 2002 ; Carman and Springer, 2003 ; van Buul et al., 2007 ) , tetraspanins, and actin-binding proteins at the contact area with leukocytes ( Barreiro et al., 2002 .
In this study, we demonstrate that before leukocyte binding, the apical plasma membrane of living endothelial cells possesses specialized microdomains containing tetraspanins and adhesion receptors (VCAM-1 and ICAM-1), which we have termed endothelial adhesive platforms (EAPs). This particular kind of TEM promotes molecular aggregation at the nanoscopic scale (nanoclustering) of adhesion receptors to 529 DYNAMIC ANALYSIS OF ENDOTHELIAL ADHESIVE PLATFORMS • Barreiro et al.
fer (FRET) -fl uorescence lifetime imaging microscopy (FLIM) analysis. For this purpose, we generated functional VCAM-1 and ICAM-1 chimeras fused to monomeric EGFP (mEGFP) as donor and mRFP1 as acceptor. The constructs were transiently cotransfected into primary HUVECs under resting conditions to prevent up-regulation of endogenous VCAM-1 and ICAM-1 expression. We then analyzed the molecular interactions at a nanometric scale
Analysis of homo-and heterophilic interactions of ICAM-1 and VCAM-1 in living endothelial cells
Because cytoskeletal anchorage cannot account for adhesion receptor corecruitment, we investigated the potential formation of VCAM-1 -ICAM-1 heterodimers at the apical membrane of living primary endothelial cells by F ö rster resonance energy trans- Figure 1 . VCAM-1 and ICAM-1 are copresented at lymphocyte -endothelium contact sites independently of ligand binding and actin anchorage. (A) K562 ␣ 4 or LFA-1 was adhered (30 min) to TNF-␣ -activated HUVECs. Samples were fi xed and double stained with anti -VCAM-1 (P8B1) and biotin-conjugated anti -ICAM-1 (MEM111). Confocal stacks were obtained, and orthogonal maximal projections and vertical three-dimensional reconstructions of the whole series are displayed. (B) Human T lymphoblasts were pretreated (5 min) with 10 μ M BIRT377 or 10 μ g/ml BIO5192 to inactivate LFA-1 or VLA-4 and were added to TNF-␣activated HUVECs for 5 min. Fixed cells were double stained as in A. Confocal stacks were obtained, and a representative section from each treatment is shown together with its corresponding colocalization histogram and a mask showing the distribution of double green-red pixels (marked regions) within the cell. (C) Resting HUVECs transfected with VCAM ⌬ Cyt were incubated with K562 ␣ 4 (i), K562 LFA-1 (ii), or T lymphoblasts (iii). maining pixels (12%) showed positive FRETeff of 14 -34% and were localized in clusters at the membrane ( Fig. 2 A ) . In contrast, the analysis showed no signifi cant molecular interactions of the VCAM-1 -VCAM-1, ICAM-1 -VCAM-1, and VCAM-1 -ICAM-1 pairs ( Fig. 2 , B -D ). Thus, under these conditions, homophilic ICAM-1 -ICAM-1 interactions, but not VCAM-1 -VCAM-1 or heterophilic VCAM-1 -ICAM-1 interactions, are detected on the plasma membrane of living primary endothelial cells.
between ICAM-1 -ICAM-1, VCAM-1 -VCAM-1, and ICAM-1 -VCAM-1 by alternately using each receptor as donor ( Fig. 2 ) . The fl uorescence lifetime of the donor in each cotransfection was compared with that of singly transfected ICAM-1 -or VCAM-1 -mEGFP (donor standards in Fig. S1 A, available at http://www.jcb .org/cgi/content/full/jcb.200805076/DC1). In the case of ICAM-1 -ICAM-1 interaction, although most pixels were below the FRET detection threshold (FRET effi ciency [FRETeff] ≤ 10%), the re- Figure 2 . VCAM-1 and ICAM-1 do not interact at the plasma membrane. Endothelial cells were cotransfected with mEGFP -mRFP1 pairs (ICAM-1 -ICAM-1, VCAM-1 -VCAM-1, ICAM-1 -VCAM-1, and VCAM-1 -ICAM-1). A representative FRET -FLIM analysis using the phasor plot is shown for each pair. The sine (s) and cosine (g) transforms of the lifetime data measured in the frequency mode generate the coordinate system presented in the phasor ( Digman et al., 2008 ) . Fluorescence intensity (F. intensity) images are in pseudocolor (left), and corresponding mEGFP lifetime distributions are shown in the plots after the phasor transformation (right). In each phasor plot, the green line represents 0% FRETeff and the red line marks 50% FRETeff ( Caiolfa et al., 2007 ) . The black circular cursors in the phasor plots select the subset of pixels shown in the correlated FLIM images (pink mask for positive FRET and white mask for negative FRET; middle). For the ICAM-1 -ICAM-1 pair (A), most pixels lie very close to the green line (FRETeff ≤ 10%; negligible), but 12% of pixels exhibit FRETeff of 14 -34%. These positive pixels are localized in clusters, as shown by the FLIM image (pink mask). Other protein pairs (B -D) show phasor distributions indistinguishable from that of the negative controls ( Fig. S1 A, available at http://www.jcb .org/cgi/content/full/jcb.200805076/DC1). a.u., arbitrary units. Bars, 20 μ m.
affected to a lesser extent, exhibiting a variable slowdown in FRAP recovery curves compared with analyses of the same molecules at other plasma membrane regions of similar size ( Fig. S3 A) . Statistical analyses showed that ICAM-1 engagement had the greater effect on CD9 mobility, whereas CD151 was more affected by VCAM-1 engagement (Table S2 and Fig.  S3 A). These data thus suggest a degree of specifi city among tetraspanin -partner interactions within EAPs. GPI-EGFP diffusion was not altered at docking structures ( Fig. 3 E ) .
Differences in the diffusion of tetraspanins and adhesion receptors could be related to their differential anchorage to the actin cytoskeleton. We therefore analyzed the dynamics of a cytoplasmic tail -truncated mutant of ICAM-1 (ICAM-1 ⌬ Cyt-EGFP), which lacks actin -cytoskeleton linking activity. Freed of cytoskeletal constraints, this truncated ICAM-1 diffused at the plasma membrane more rapidly than the full-length receptor ( Fig. S3 B) . ICAM-1 ⌬ Cyt-EGFP also had a faster fl uorescence recovery rate than the wild-type molecule at docking sites with K562 LFA-1 cells, indicating that stabilization of the ICAM-1 -LFA-1 interaction also implies anchorage of ICAM-1 to the endothelial F-actin cytoskeleton ( Fig. S3 B) .
To accurately estimate the diffusional features of individual EAP components, we applied fl uorescence correlation spectroscopy (FCS) to mEGFP-tagged ICAM-1, VCAM-1, CD9, and CD151 expressed in living primary human endothelial cells. The autocorrelation functions (ACFs) derived from fl uorescence intensity traces were best fi tted using an anomalous diffusion model. We found that all of these proteins showed a pattern of local diffusion confi nement, with ICAM-1 and VCAM-1 showing slower overall diffusion than tetraspanins, correlating with a higher diffusion anomality (smaller ␣ coeffi cient values; Fig. 4 A ) . Tetraspanins showed a higher relative frequency of faster diffusion than adhesion receptors ( Fig. S4 A, available at http://www .jcb.org/cgi/content/full/jcb.200805076/DC1). This might indicate a more confi ned diffusion of VCAM-1 and ICAM-1 within EAPs versus a more dynamic exchange of tetraspanins among different microdomains. Furthermore, we found a pronounced decrease in the molecular mobility of CD9 within docking structures compared with nude plasma membrane ( Fig. 4 B ) , concurring with data obtained by FRAP analysis.
Specifi city of tetraspanin -adhesion receptor interactions within EAPs
Next, we performed additional FRET -FLIM analyses in living endothelial cells to explore the molecular interactions among CD9, CD151, ICAM-1, and VCAM-1. These assays confi rmed the homophilic CD9 -CD9 and heterophilic CD9 -CD151 interactions ( Fig. 5, A and B ) previously shown by biochemical studies (for review see Hemler, 2005 ) . In addition, we found that CD9 preferentially interacted with ICAM-1 and CD151 with VCAM-1, with FRETeff values close to those detected between tetraspanins ( Fig. 5, C and D ) . In contrast, VCAM-1 -CD9 and ICAM-1 -CD151 interactions were scarce throughout the cell membrane and were not detected in all cells studied (Fig. S1 , B and C). These results further support the existence of differential molecular interactions in EAPs and strongly suggest that there are preferential associations between specifi c adhesion receptors
Tetraspanin microdomains are involved in the formation of specialized EAPs
Because there is no heterophilic ICAM-1 -VCAM-1 interaction, the coclustering of adhesion receptors may involve their lateral association with specific plasma membrane microdomains. We have previously found that the CD9, CD81, and CD151 tetraspanins concentrate at docking structures around primary human leukocytes and coprecipitate together with VCAM-1 and ICAM-1 . In this study, we found that tetraspanin proteins were also enriched at docking sites in the K562 ␣ 4 and LFA-1 adhesion models ( Fig. S2 A, available at http://www.jcb.org/cgi/content/full/ jcb.200805076/DC1). To examine this association further, we engaged endothelial surface proteins with specifi c magnetic bead -coated antibodies, fi nding that engagement of either CD9 or CD151 corecruited both ICAM-1 and VCAM-1. Conversely, beads coated with anti -VCAM-1 corecruited ICAM-1 and vice versa, and both antibodies clustered tetraspanins. In contrast, anti -vascular endothelial cadherin (VE-cadherin)coated beads did not signifi cantly recruit ICAM-1, VCAM-1, or tetraspanins above basal levels (Fig. S2 , B and C; and not depicted).
Sucrose gradient fractionation of lysates of TNF-␣activated HUVECs showed that most tetraspanins are soluble under these conditions and migrate with the dense fractions (F1 -F7) together with ICAM-1 and VCAM-1, which were not found in lipid raft fractions containing caveolin ( Fig. S2 D) . These results strongly suggest that endothelial tetraspanin microdomains containing VCAM-1 and ICAM-1 are distinct from classical biochemically defi ned lipid rafts and may constitute specialized, organized membrane structures, which we have termed EAPs.
Molecular dynamics at EAPs
To explore the molecular dynamics of tetraspanins and adhesion receptors at EAPs, we fi rst used FRAP to study the diffusional properties of EGFP-tagged CD9, CD151, VCAM-1, and ICAM-1 at the nude apical plasma membrane of HUVECs in comparison with the lipid raft marker GPI-EGFP ( Fig. 3 A and Table S1 , available at http://www.jcb.org/cgi/content/full/ jcb.200805076/DC1; Sharma et al., 2004 ) . The derived apparent diffusion coeffi cient (Table S1 ) and the immobile fraction (1 Ϫ R) for each protein ( Fig. 3 A ) were calculated. GPI-EGFP showed the highest mobility ( ‫ف‬ 1 μ m 2 /s, as previously described in Kenworthy et al., 2004 ) . Tetraspanins and ICAM-1 behaved similarly (D = ‫ف‬ 0.5 μ m 2 /s), whereas VCAM-1 seemed to diffuse slower (D = ‫ف‬ 0.3 μ m 2 /s) and exhibited a higher immobile fraction.
To assess the infl uence of leukocyte adhesion on EAP dynamics, FRAP was performed on endothelial docking structures induced by engagement of K562 ␣ 4 or LFA-1 ( Fig. 3, B -D ). The most notable effects were when an endothelial adhesion receptor was specifi cally bound to its ligand, a greater proportion of the protein population remained immobile, and the mobility of the residual mobile fraction was locally restricted ( Fig. 3 , C and D ; and Fig. S3 A, available at http://www.jcb.org/cgi/content/full/ jcb.200805076/DC1). Other nonligated EAP components were ( Fig. S4, B and C; and not depicted). In contrast, VE-cadherin does not coprecipitate tetraspanins ( Fig. S4 B) , and its engagement does not induce corecruitment of EAP components (Fig. S2 , B and C), suggesting its exclusion from these specialized membrane microdomains. and tetraspanins. In further biochemical and microscopy anal yses, we searched for other endothelial receptors that might interact with tetraspanins and cluster at the leukocyte -endothelial contact area independently of ligand binding, identifying PECAM-1/ CD31, CD44, JAM-A, and ICAM-2 as putative EAP components infection ( Zhu et al., 2002 ; Takeda et al., 2003 ; Ho et al., 2006 ) , and VCAM-1 -and ICAM-1 -mediated lymphocyte adhesion strength and transmigration under fl ow in vitro . However, the mechanism of action of LEL peptides has not been elucidated yet. FCS analyses showed that CD9-LEL-GST decreased the diffusion of CD9 and CD151 ( Fig. 6 , A -C ), suggesting that interference with CD9, the most abundant EAP component, has a critical effect on EAP organization and dynamics.
Role of tetraspanins in the molecular dynamics and nanoclustering of adhesion receptors in EAPs
To investigate the role of tetraspanins in the molecular dynamics of EAPs, we used the tetraspanin-blocking peptide CD9 -large extracellular loop (LEL) -GST. Tetraspanin-blocking peptides have been used to perturb functions regulated by tetraspanin microdomains, such as egg -sperm fusion, monocytic giant cell formation and HIV and ICAM-1 and VCAM-1 adhesion receptors in EAPs, both at nude apical membrane and in the docking structures formed between endothelial cells and adhered leukocytes. Our results show that EAPs play an essential role in the spatial organization of the membrane and in the recruitment of ICAM-1 and VCAM-1 toward the contact area with adherent leukocytes, regulating endothelial cell adhesiveness ( Fig. 8 , right) .
The coclustering of VCAM-1 at docking structures induced by ligand engagement of ICAM-1 and vice versa initially suggested that these adhesion receptors might interact with each other. However, the FRET -FLIM analysis only showed significant association for ICAM-1 -ICAM-1, with negligible heterophilic interactions between ICAM-1 and VCAM-1. The existence of ICAM-1 homodimers has been shown before by biochemical approaches Reilly et al., 1995 ) . However, BIAcore affi nity measurements revealed that a single ICAM-1 monomer, not dimeric ICAM-1, represents the complete, fully competent LFA-1 -binding surface ( Jun et al., 2001 ) .
The possible role of tetraspanins in the corecruitment of these adhesion receptors was confi rmed by additional FRET -FLIM analysis, which showed homophilic (CD9 -CD9) and heterophilic (CD9 -CD151) tetraspanin interactions as well as association of these tetraspanins with the adhesion receptors studied. Interestingly, the molecular interactions among tetraspanins and adhesion receptors show signifi cant specifi city, with a preferential association of CD9 with ICAM-1 and of CD151 with VCAM-1. Although full elucidation of the mole cular complexity of EAPs requires additional studies, it is very likely that other tetraspanins and adhesion receptors are contained in these structures, interacting among themselves and with CD9, CD151, ICAM-1, and VCAM-1. Indeed, our data indicate that tetraspanin CD81 , CD44, PECAM-1/CD31, JAM-A, ICAM-2, and E-selectin (Fig. S4 , B and C; and not depicted) all associate with tetraspanin CD9 and are included in EAPs. However, further studies are required to determine whether there are distinct kinds of EAPs with defi ned protein composition.
The diffusional behavior of EAP components was investigated by combining FRAP and FCS analyses; FRAP provided a qualitative overview of EAP diffusion at a microscopic level, and FCS allowed us to accurately quantify diffusion coeffi cients of EAP components at the single-molecule level. FRAP analyses indirectly examine the diffusion of an overall molecular population within a microscopic area at nude membrane or at sites of leukocyte anchorage. Therefore, a mixed steady-state molecular population (comprising proteins bound or unbound to cytoskeleton, coupled to partners, etc.) is considered for each measurement. From FRAP data collected at nude plasma membrane, we distinguished differences between the immobile fractions of VCAM-1 and ICAM-1. These data indicate important differences in the binding of these receptors to cortical cytoskeleton that deserve further analysis. In this regard, it has been described as a direct association of VCAM-1 with ezrin and moesin ( Barreiro et al., 2002 ) , whereas ICAM-1 interacts with ␣ -actinin and colocalizes but does not directly associate with ezrin/ radixin/moesin proteins in endothelial cells ( Romero et al., 2002 ; Celli et al., 2006 ) . The higher frequency of transiently immobilized
The spatial organization of EAPs was assessed by scanning electron microscopy combined with immunogold labeling of VCAM-1 and ICAM-1. We found submicrometer-sized homo-and heteroclusters of these adhesion receptors throughout the nude apical plasma membrane ( Fig. 7 A and Fig. 8 ,  left) , supporting the concept of preexistent EAP microdomains. Localized high density clustering was observed at the microvilli of docking structures around adherent leukocytes (shown for ICAM-1; Fig. 8 , right) , indicating that EAPs coalesce during the formation of such structures. Quantifi cation of clusters and particles/cluster in cell membrane areas expressing high or low content of ICAM-1 and VCAM-1 revealed an increase in cluster number in those areas containing higher numbers of adhesion molecules, whereas there was no signifi cant change in the number of particles per cluster. EAPs therefore seem to be size restricted to nanometric dimensions (apparent mean size of ‫ف‬ 300 nm; Fig. 7 A and Fig. S5 A, available at http://www.jcb .org/cgi/content/full/jcb.200805076/DC1).
Nearest neighbor analysis of the spatial pattern of immunogold-labeled ICAM-1 and VCAM-1 in the presence of CD9-LEL-GST showed that receptor spacing was increased compared with cells not treated or treated with heat-inactivated peptide ( Fig. 7 B ) . CD9-LEL-GST also reduced the percentage of clustered receptors ( Fig. 7 C ) and partially disrupted their patterned distribution on the cell membrane ( Fig. S5 B) . CD9-LEL-GST thus seems to compete with endogenous CD9 for binding to itself homophilically and to other tetraspanins and partners, probably by blocking interactions and imposing steric hindrance, resulting in slower diffusion of EAP components and reduced receptor clustering, which in turn decreases adhesiveness.
Discussion
Plasma membranes contain different kinds of organized microdomains, all of which play important roles in sensing and processing information from the cell exterior. The composition and biophysical properties of lipid rafts, which are based on lipidprotein interactions, have been extensively studied ( Kenworthy et al., 2004 ; Sharma et al., 2004 ) . Much less is known about TEMs, which are primarily based on protein -protein interactions. Previous microscopy analysis of fi xed samples and biochemical studies indicated that a network of specifi c protein -protein interactions may exist between tetraspanins and associated partners ( Claas et al., 2001 ; Nydegger et al., 2006 ) . In this study, we have used advanced analytical microscopy and single-molecule spectroscopy techniques to characterize the dynamic features and biophysical properties of TEMs in living primary human endothelial cells. Our results provide the fi rst description of tetraspanin microdomains as physical entities in living cells with dynamic features that clearly differ from lipid rafts. The transiently transfected primary human endothelial cells used are a physiologically relevant cell model that expresses an appropriate repertoire of membrane tetraspanins and adhesion receptors. We show that these cells bear a particular kind of TEM enriched in membrane adhesion receptors to facilitate leukocyte -endothelial interactions that we have termed EAPs ( Fig. 8 , left) . Moreover, we have characterized the molecular interactions of CD9 and CD151 tetraspanins A and B) Representative FCS measurements at the plasma membrane of endothelial cells transiently cotransfected with CD9-mRFP1 (A) and CD151-mEGFP (B) and treated with 250 μ g/ml active or heat-inactivated CD9-LEL-GST. The fi gure shows the fl uorescence intensity image, the ACF (black lines) derived from the fl uorescence intensity trace acquired at the point marked with a white cross, the best-fi tted curve using an anomalous diffusion model (red lines), and D and ␣ coeffi cients. (C) Box-whisker plots show distributions of D and ␣ values (as in Fig. 4 ) . Statistical analysis and number of experiments are presented in Table S3 (available at http://www.jcb.org/cgi/content/full/jcb.200805076/DC1). kCPS, kilo counts per second.
prototypic lipid raft proteins ( Lenne et al., 2006 ) . Moreover, GPI-EGFP was unaffected by engagement of integrin-bearing leukocytes, whereas EAP dynamics were altered. In fact, the delay observed for nonligand-engaged EAP components at docking structures could well be the result of their transient interaction with ligand-immobilized ICAM-1 or VCAM-1. These immobile complexes at docking sites could thus act as physical constraints on the mobility of the overall molecular populations analyzed, producing a net restriction in local diffusion. The fact that each adhesion receptor is less affected than tetraspanins by ligand engagement of the other receptor supports a model of tetraspanin-dependent receptor coclustering. The higher relative frequency of fast diffusion by tetraspanins indicates that they are more dynamically exchanged between EAPs than are adhesion receptors, further supporting their role as the active organizers of these microdomains. Moreover, adhesion receptors molecules in the case of VCAM-1 might produce a decrease in the average apparent D coeffi cient for this molecular species because FRAP calculations are made on an overall molecular population. In fact, these apparent D coefficients fitted by a simple diffusion model do not reveal the real diffusional behavior of the receptors, which turned out to be undistinguishable when precisely measured by single-molecule FCS analysis fi tted by an anomalous diffusion model. Diffusional analyses by FCS thus complement the FRAP data.
When we used FRAP to analyze the diffusion of GPI-EGFP, a lipid raft marker widely used in microscopy studies ( Varma and Mayor, 1998 ; Kenworthy et al., 2004 ) , we found that this protein diffused much faster than tetraspanins and other EAP components and showed almost full fl uorescence recovery. In addition, most D coeffi cients for EAP proteins that we have obtained using FCS are much lower than those reported for Figure 7 . Tetraspanins regulate endothelial adhesion receptor nanoclustering. (A) TNF-␣ -activated endothelial cells were fi xed and stained with anti -VCAM-1 or anti -ICAM-1 followed by 40-nm gold immunolabeling. Representative scanning electron microscope negative images of the endothelial plasma membrane are shown. Mean cluster number and size ± SEM for VCAM-1 -and ICAM-1 -containing microdomains analyzed in images with low or high particle number (i.e., indirect measurement of low or high receptor expression). Clustering parameters: ␦ = 100 and = 1 (see Materials and methods). (B) Gold particle coordinates from individual scanning electron microscope images (15-μ m 2 plasma membrane) were used to compute nearest neighbor distances (see Materials and methods). Graphs show comparison of VCAM-1 or ICAM-1 nanoclustering based on nearest neighbor profi les from control, CD9-LEL-GST -, and heat-inactivated CD9-LEL-GST -treated samples with statistically comparable numbers of particles. The bar plot represents the mean of the Euclidean distance of the nearest neighbor for the total of n particles in the several images analyzed for each treatment. (C) Clustering rates were computed from the samples in B (see Materials and methods). Clustering parameters: VCAM-1, ␦ = 205 and = 2; and ICAM-1, ␦ = 140 and = 2. Statistical signifi cance in the fi gure was based on a Student ' s t test.
with ICAM-1 -ICAM-1 interactions, which supports the central role of tetraspanins in the molecular dynamics of adhesion receptors, strengthening the concept of EAPs as the basic organizational unit of endothelial adhesion receptors on the apical plasma membrane.
The regulation of endothelial adhesion receptor avidity by their inclusion in tetraspanin-enriched EAPs represents a conceptual advance in the understanding of leukocyte -endothelium interactions. Leukocyte integrin activity can be regulated by conformational changes (affi nity) and/or clustering at the plasma membrane (avidity; Luo et al., 2007 ) . In contrast, no regulatory mechanism apart from transcription has been described before for endothelial integrin ligands ( Collins et al., 1995 ) . Our data demonstrate that tetraspanin and adhesion receptor colocalization does indeed refl ect highly specifi c and organized interactions among them, forming specialized TEMs (EAPs; Fig. 8 , left and middle panels illustrate preformed EAPs). Inclusion of ICAM-1 and VCAM-1 in EAPs allows homo-and heteroclustering of exhibit a higher anomality in diffusion, which accounts for their preferential binding to cortical cytoskeleton and transient immobilization compared with tetraspanins ( Sala-Valdes et al., 2006 ) . However, further studies are needed to defi ne the residence time of molecules within EAPs. The mix of endogenous and exogenous protein populations precludes precise determination of the stoichiometry of submicrometer-sized EAPs. Nonetheless, analysis of brightness from the photon-counting histograms obtained during FCS measurements revealed the existence of complexes containing more than one fl uorescently labeled molecule. This was also confi rmed by fl uorescence cross-correlation spectroscopy analysis (unpublished data).
FRET analysis confi rmed a degree of specifi city inside the preexistent EAPs before leukocyte binding. The preferential interactions of ICAM-1 with CD9 and VCAM-1 with CD151 are evident in the FRETeff for these pairs. FRET -FLIM analysis shows that interactions between tetraspanins and tetraspanin adhesion receptors are more frequent compared Fixed cells were stained with anti -ICAM-1 and 40-nm immunolabeled gold. A representative negative scanning electron microscopy image shows the preferential localization of gold particles at the microvilli of the endothelial docking structure formed around a lymphoblast, where EAPs coalesce.
Cell adhesion, immunofl uorescence, and confocal microscopy
Confl uent HUVECs on FN-coated coverslips were activated with TNF-␣ . Then, K562 clones or T lymphoblasts were added. Adhesion of K562 LFA-1 to activated HUVEC monolayers was assayed in the presence of 1 mM Mn 2+ to activate integrins. Where indicated, T lymphoblasts were treated with 10 μ g/ml BIO5192 or 10 μ M BIRT377 for 5 min before adhesion assay. After incubation, samples were washed and fi xed in 4% paraformaldehyde and processed for immunofl uorescence ( Yanez-Mo et al., 1998 ) . A series of optical sections were obtained at 21 ° C with a confocal laserscanning unit (TCS-SP5; Leica) coupled to a microscope (DMI6000; Leica) using an HCX PL APO CS 63 × NA 1.3 glycerol immersion objective. Images were analyzed with confocal software (Leica).
Bead adhesion
TNF-␣ -activated HUVECs were incubated for 30 min with Dynabeads coated with antitetraspanin, anti -VCAM-1, or anti -VE-cadherin mAb (Invitrogen) and were fi xed and stained with biotinylated anti -ICAM-1 mAb.
Sucrose density gradient fractionation
Confl uent TNF-␣ -activated HUVECs were rinsed with PBS and lysed for 20 min in 250 μ l of 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1% Brij96 at 4 ° C. The cell lysate was homogenized by passing the sample through a 22-gauge needle. The extract was brought to 40% sucrose (wt/wt) in a fi nal volume of 4 ml and placed at the bottom of an 8-ml 5 -30% linear sucrose gradient. Gradients were ultracentrifuged to equilibrium for 20 h at 39,000 rpm at 4 ° C in a rotor (SW41; Beckman Coulter). 1-ml fractions were harvested from the bottom of the tube. Aliquots from each fraction were subjected to SDS-PAGE and Western blotting with appropriate antibodies.
FRAP
Cells transfected with EGFP fusion proteins (VCAM-1 -, ICAM-1 -, CD9-, CD151-, ICAM-1 ⌬ Cyt -, and GPI-EGFP) were plated on FN-coated coverslips.
both molecules at the contact area with the adhered leukocyte independent of ligand binding and actin cytoskeleton anchorage ( Fig. 8 , right and middle panels illustrate a docking structure around the adhered leukocyte). This novel role of tetraspanins seems to represent a supramolecular level of regulation not previously envisaged for integrin ligands. Additional tetraspanin molecules could be involved in regulating the molecular dynamics and organization of EAPs, among them CD81, which is also localized at endothelial docking structures and which, in leukocytes, is able to act as a homeostatic avidity facilitator of VLA-4 ( Feigelson et al., 2003 ) .
The important role of tetraspanins in the molecular dynamics of EAPs is also supported by our results with the CD9-LEL-GSTblocking peptide. It seems evident that this CD9-blocking peptide perturbs EAP dynamics by competing with endogenous CD9 for binding to partners and other tetraspanins. As CD9 is the most abundant of the analyzed EAP components, intercalation of CD9blocking peptides into EAPs would alter the patterned distribution and mobility of all the proteins embedded within them, providing an explanation for the decrease in receptor-binding strength. EAPs thus appear to endow ICAM-1 and VCAM-1 with the proper spatial distribution to exert their adhesive functions, promoting their clustering and, therefore, enhancing their avidity for their ligands expressed on leukocytes. Supramolecular organization at the nanoscale has been reported for other receptor molecules, including LFA-1 integrin on leukocytes and the C-lectin receptor dendritic cell -specifi c ICAM-grabbing nonintegrin on dendritic cells ( Cairo et al., 2006 ; Cambi et al., 2006 ; de Bakker et al., 2007 ) . Whether these molecules are included within TEMs on the leukocyte plasma membrane is an interesting issue that deserves investigation.
With the reagents currently available, it is not possible to address whether endothelial receptors undergo conformational change because of their interaction with tetraspanins. However, it will be of interest to identify the critical amino acid sequences in tetraspanins and adhesion receptors that participate in their lateral interactions. This information would have potential use in the future design of therapeutic blocking agents directed at reducing the adhesiveness of endothelial cells toward circulating leukocytes. Such agents might provide novel therapeutic strategies for the treatment of chronic infl ammatory and autoimmune diseases in a more general manner than existing therapies focused on the inhibition of a particular adhesion pathway mediated by a single integrin ligand.
In summary, our data indicate that EAPs are specialized tetraspanin-based membrane microdomains that regulate the avidity of several adhesion receptors integrated in them, acting as a mechanism to organize molecules with similar characteristics and functions and thereby facilitating their coordinated action in rapidly occurring processes such as extravasation.
Materials and methods

Cells
HUVECs were cultured as described previously ( Barreiro et al., 2002 ) . K562 erythroleukemic cells, which endogenously express ␤ 1 integrin, were stably transfected with integrin ␣ 4 to yield cells expressing ␣ 4 ␤ 1 integrin/VLA-4 or with integrin ␣ L ␤ 2/LFA1. K562 clones and T lymphoblasts were cultured as described previously ( Barreiro et al., 2002 ) . Integrin quenched by 50% FRET in the presence of the acceptor and with different contributions from cell autofl uorescence (red line in all phasor plots). In all of our experiments, phasors resulting from any combination of unquenched donors, FRET-quenched donors, and cell autofl uorescence have been found within the area delimited by the green and red lines in the phasor plots. The localization and distribution of the phasors of mEGFP constructs were not affected by the kind of protein linked to the fl uorophore or by the cells in which they were expressed. Endogenous untagged proteins expressed in our cell model may interfere with FRET. To minimize interaction between endogenously and exogenously expressed tagged proteins in FLIM analyses, quantifi cations were performed in resting endothelial cells, where tetraspanin expression is unaltered, ICAM-1 levels are low, and VCAM-1 plasma membrane expression is negligible. Given that endogenous CD151 and CD9 expression is much higher than ICAM-1 in resting endothelial cells, FRETeff from measurements involving tetraspanin proteins may be underestimated. Moreover, because CD9, CD151, and ICAM-1 can homodimerize, the association of two green or red molecular species makes hetero-FRET events even more improbable. To substantiate the experimental data on the absence of ICAM-1 -VCAM-1 heterodimers, ICAM-1 or VCAM-1 was used indistinctly as a donor in FRET -FLIM experiments.
FCS
HUVECs were transiently single or double transfected as for FLIM and treated either with growth factors (resting conditions) or with 20 ng/ml TNF-␣ (activated conditions). Intensity fl uctuations were recorded on the described setup ( Caiolfa et al., 2007 ) based on a dual-channel confocal fl uorescence correlation spectrometer (ALBA; ISS, Inc.) equipped with avalanche photodiodes (SPCM-AQR-15; PerkinElmer) and interfaced to an inverted microscope (TE300; Nikon). A 60 × 1.2 NA plan Apo water immersion objective was used. Excitation was provided at 488 nm by a tunable Ar ion laser (Melles Griot) and at 594 nm by a HeNe laser (Melles Griot). Calibration and data collection were performed according to the procedures previously described ( Caiolfa et al., 2007 ) .
The ACFs were best fi tted using the anomalous diffusion model ( Banks and Fradin, 2005 ) , according to the equation
where N is the average number of molecules in the excitation volume, is the increment of time, D is the diffusion time, and ␣ is the anomality coefficient. Accordingly, the diffusion coeffi cient (D) is derived from the relationship D = 2 /4 ␣ .
In FCS experiments, endogenous proteins were in excess compared with corresponding fl uorescent-tagged variants, minimizing artifacts as a result of differences in local concentrations of the latter. FCS experiments were performed both either in resting or in TNF-␣ -activated HUVECs, not fi nding statistically signifi cant differences in diffusion between the treatments.
Scanning electron microscopy
Endothelial monolayers were activated with TNF-␣ in the absence or presence of 250 μ g/ml of active or heat-inactivated (5 min at 90 ° C) CD9-LEL-GST peptide. T lymphoblasts were added when indicated. Cells were fi xed in 2% paraformaldehyde/PBS and immunolabeled with P8B1 (anti -VCAM-1), Hu5/3 (anti -ICAM-1), or biotinylated MEM-111 (anti -ICAM-1) as primary antibodies and 40 nm of gold-coupled anti -mouse antibody or 15 nm of gold-coupled streptavidin (British Biocell International) as detection reagents. Samples were fi xed in 2.5% glutaraldehyde/PBS, sequentially dehydrated, critical point dried, and covered with a 5-nm carbon layer. Images were obtained with a scanning electron microscope (S-4100; Hitachi) at an acceleration voltage of 12 kV and a 4-mm working distance. Images were processed with Metamorph software (MDS Analytical Technologies).
Nearest neighbor distances and k nearest neighbor (knn) profi les
For each image, we computed the knn distance vector that contains in its i th position the mean of the distances between objects and their i th nearest neighbor. Comparison of knn profi les allows us to establish similarities and discrepancies between different treatments in terms of aggregation and dispersion of the clouds of points in the image. The knn distances were assumed to be independent realizations of a normal distribution (the null hypothesis of normality could not be rejected using a Shapiro-Wilk test). Because the knn profi le might be dependent on the number of objects, the analysis was performed After 24 h, cells were stimulated with TNF-␣ , and FRAP experiments were performed within 48 h of plating. To analyze FRAP at the endothelial docking structure, an adhesion assay was conducted using K562 ␣ 4 or LFA-1. Live cell microscopy was performed with a confocal laser-scanning unit (TCS-SP2; Leica) coupled to a microscope (DMIRBE; Leica) using the 488-nm Ar laser line and an HCX PL APO lambda blue 63 × NA 1.4 oil immersion objective. During observation, plates were maintained at 37 ° C in a 5% CO 2 atmosphere using an incubation system (LaCon GbR/PeCon GmbH). Laser power for bleaching was maximal but was reduced to 10% for imaging. 10 single-section prebleach images were acquired followed by three iterative bleach pulses of 1.7 s each. 10 single-section images were then collected at 1.7-s intervals followed by 20 images every 10 s and fi nally 15 images every 30 s for a total experimental time of ‫ف‬ 650 s.
Fluorescence recovery in the bleached region was measured as average signal intensity. All recovery curves were generated from backgroundsubtracted and bleaching-corrected images. Moreover, the fl uorescence signal was normalized to the prebleach signal in the same region of interest.
The mobile fraction (R) corresponds to the fi nal value of the recovered fl uorescence intensity, and the immobile fraction is obtained as 1 Ϫ R. The half-time of recovery is the time from bleaching to the time when the fl uorescence intensity is half of the fi nal recovered intensity. All three variables were directly obtained from the normalized mean fl uorescence recovery curves.
The averaged recoveries were fi tted with the equation
where F 0 = fl uorescence intensity at the fi rst time point after bleach, F 0 = fl uorescence intensity before bleach, R = mobile fraction, and t 1/2 = half recovery time. Apparent diffusion coeffi cients from averaged recovery halftimes were derived using a simple Brownian diffusion model. Averaged immobile fractions (1 Ϫ R) were derived from averaged fi tted curves.
The possible perturbation of membrane dynamics that might result from differential exogenous expression of tagged proteins was overcome in FRAP experiments by making a large number of measurements in several batches of transiently transfected primary endothelial cells and exhaustive statistical analysis. To assess the statistical signifi cance of differences between FRAP recovery curves, we derived a t test analysis on the average fi tted curves for each protein in each condition.
Hetero-FRET by donor FLIM in intact living cells
HUVECs were single transfected with mEGFP standards or cotransfected with mEGFP -mRFP1 pairs and seeded on FN-coated glass-bottomed dishes. After 24 h and without TNF-␣ treatment, the culture medium was replaced with a phenol red -free medium for optimal image acquisition. FLIM was performed using the digital frequency domain method and the new FLIM box, recently described in detail ( Colyer et al., 2008 ) , which were implemented at the Laboratory of Fluorescence Dynamics (University of California, Irvine, Irvine, CA) on a commercial confocal system (FluoView 1000; Olympus). Excitation was provided by a modulated 471-nm diode laser (ISS, Inc.). A 40 × 1.2 NA water immersion objective (Carl Zeiss, Inc.) was used. Data were acquired and processed by SimFCS software (developed at the Laboratory of Fluorescence Dynamics). The scan area (256 × 256 pixels) corresponds to 32 × 32 μ m 2 . Before cell measurements, concentrated fl uorescein at pH 9.0 was measured. Fluorescein lifetime (4.04 ns) was determined separately in a fl uorometer (PC1; ISS, Inc.).
The FLIM analysis for deriving FRETeff was performed using the phasor FLIM method recently described ( Caiolfa et al., 2007 ; Digman et al., 2008 ) and commented on ( Wouters and Esposito, 2008 ) . The contour plots associated with each image show the entire distribution of the donor fl uorescence lifetimes in the image. The distribution was obtained by converting the multiexponential fl uorescence decays acquired in each pixel into the graphical representation of a phasor. In brief, the phasor transformation does not assume any fi tting model for fl uorescence lifetime decays. It simply expresses the overall decay in each pixel in terms of a point of (s, g) polar coordinates in the so-called " universal circle " ( Redford and Clegg, 2005 ) . In each plot, the green line represents the position of all phasors having 0% FRETeff and variable cellular autofl uorescence. These points were derived from the lifetime analysis in cells expressing only the donor molecules, whereas untransfected cells were used as a control for autofl uorescence. Once the phasors of the unquenched donors and of the cell autofl uorescence (green line in the phasor plots) are known, the FRET trajectory in the phasor plot can be calculated according to the classical relationship FRETeff = [1 Ϫ ( donor -acceptor )/ donor ] and defi ne the mean phasors of mEGFP constructs
